{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:35:23Z","timestamp":1767792923747,"version":"3.49.0"},"reference-count":58,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"research fund of Hanyang University","award":["(HY-202500000001668)"],"award-info":[{"award-number":["(HY-202500000001668)"]}]},{"name":"National Research Foundation of Korea (NRF) grant funded by the Korea government","award":["(RS-2025-00557268)"],"award-info":[{"award-number":["(RS-2025-00557268)"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2025,6,26]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Limited information is available on the influence of serologic status and different types of disease-modifying antirheumatic drugs (DMARDs) on risk of pneumonia. This study aimed to evaluate the risk of pneumonia according to rheumatoid arthritis (RA) seropositivity and type of DMARD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This population-based cohort study enrolled individuals with RA (RA cohort, n=41\u2009187) and 1:5 age-matched and sex-matched controls (n=205\u2009935) between 2010 and 2017. Participants were followed from 1 year after RA diagnosis or matched control date until the first occurrence of pneumonia, pneumonia-related hospitalisation, death or 31 December 2019. The risks of pneumonia and related hospitalisation were evaluated according to serological status and type of DMARD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up duration of 4.2 years, increased risks of pneumonia (adjusted HR (aHR) (95% CI)=1.73 (1.69 to 1.78)) and related hospitalisation (2.26 (95% CI 2.15 to 2.37)) were observed in individuals of the RA cohort compared with controls. Compared with the controls, individuals with seropositive RA showed the highest risk of pneumonia (1.86 (95% CI 1.80 to 1.92)) and related hospitalisation (2.52 (95% CI 2.39 to 2.65)), followed by those with seronegative RA (1.43 (95% CI 1.36 to 1.50) for pneumonia; 1.60 (95% CI 1.46 to 1.76) for related hospitalisation). Individuals in the RA cohort showed a higher risk of pneumonia\/related hospitalisation compared with controls, with an aHR (95%\u2009CI) of 1.77 (95% CI 1.62 to 1.94)\/3.23 (95% CI 2.82 to 3.69), respectively, for biological DMARD-exposed RA, and 1.74 (95% CI 1.69 to 1.79)\/2.22 (95% CI 2.11 to 2.33), respectively, for conventional synthetic DMARD-exposed RA. In contrast, targeted synthetic type did not show a significantly increased risk of pneumonia\/related hospitalisation (0.93 (95% CI 0.66 to 1.31)\/1.21 (95% CI 0.67 to 2.18), respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Individuals with RA showed increased risk of pneumonia and related hospitalisation, and this was especially higher in those with seropositive RA. Except for targeted synthetic DMARDs, all other types were associated with increased risk of pneumonia. These findings emphasise the need for heightened awareness of pneumonia risk in the management of RA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2024-002664","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:25:33Z","timestamp":1758792333000},"page":"e002664","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Risk of pneumonia in individuals with rheumatoid arthritis: a nationwide cohort study"],"prefix":"10.1136","volume":"12","author":[{"given":"Seong Mi","family":"Moon","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hyung","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Biostatics, College of Medicine, Catholic University of Korea, Seoul, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhee","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Family Medicine\/Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bumhee","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeonghee","family":"Eun","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4812-0653","authenticated-orcid":false,"given":"Hayoung","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyungjin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (the Republic of)"},{"name":"Department of Medical Humanities, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8128-8920","authenticated-orcid":false,"given":"Dong Wook","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Family Medicine\/Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea (the Republic of)"},{"name":"Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Science & Technology, Sungkyunkwan University, Seoul, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1269-0913","authenticated-orcid":false,"given":"Hyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"2026010701512386000_12.1.e002664.1","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112857","article-title":"Management of Rheumatoid Arthritis: An Overview","volume":"10","author":"Radu","year":"2021","journal-title":"Cells"},{"key":"2026010701512386000_12.1.e002664.2","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-000935","article-title":"Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study","volume":"5","author":"Mehta","year":"2019","journal-title":"RMD Open"},{"key":"2026010701512386000_12.1.e002664.3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","article-title":"The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment","volume":"52","author":"Listing","year":"2013","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2026010701512386000_12.1.e002664.4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/1354750X.2020.1794043","article-title":"Insights of rheumatoid arthritis biomarkers","volume":"26","author":"Kolarz","year":"2021","journal-title":"Biomarkers"},{"key":"2026010701512386000_12.1.e002664.5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/acr.24071","article-title":"Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease-Modifying Antirheumatic Drugs: Results From a Real-World Study","volume":"72","author":"Alemao","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026010701512386000_12.1.e002664.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223356"},{"key":"2026010701512386000_12.1.e002664.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.057265"},{"key":"2026010701512386000_12.1.e002664.8","first-page":"387","article-title":"The risk of hospitalized infection in patients with rheumatoid arthritis","volume":"35","author":"Smitten","year":"2008","journal-title":"J Rheumatol"},{"key":"2026010701512386000_12.1.e002664.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.21568"},{"key":"2026010701512386000_12.1.e002664.10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/acr.23824","article-title":"Risk of Hospitalized Infection and Initiation of Abatacept Versus Tumor Necrosis Factor Inhibitors Among Patients With Rheumatoid Arthritis: A Propensity Score\u2013Matched Cohort Study","volume":"72","author":"Chen","year":"2020","journal-title":"Arthritis Care & Research"},{"key":"2026010701512386000_12.1.e002664.11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.151043"},{"key":"2026010701512386000_12.1.e002664.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2010.11.032"},{"key":"2026010701512386000_12.1.e002664.13","doi-asserted-by":"publisher","DOI":"10.1002\/art.21978"},{"key":"2026010701512386000_12.1.e002664.14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem076"},{"key":"2026010701512386000_12.1.e002664.15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318211106a"},{"key":"2026010701512386000_12.1.e002664.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1692"},{"key":"2026010701512386000_12.1.e002664.17","doi-asserted-by":"publisher","DOI":"10.23838\/pfm.2021.00135"},{"key":"2026010701512386000_12.1.e002664.18","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-005267","article-title":"Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal study","volume":"11","author":"Kim","year":"2025","journal-title":"RMD Open"},{"key":"2026010701512386000_12.1.e002664.19","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.chest.2024.01.001","article-title":"Impact of Rheumatoid Arthritis and Seropositivity on the Risk of Non-Cystic Fibrosis Bronchiectasis","volume":"165","author":"Choi","year":"2024","journal-title":"Chest"},{"key":"2026010701512386000_12.1.e002664.20","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.chest.2024.02.014","article-title":"Does Rheumatoid Arthritis Increase the Risk of COPD?: A Nationwide Retrospective Cohort Study","volume":"165","author":"Chung","year":"2024","journal-title":"Chest"},{"key":"2026010701512386000_12.1.e002664.21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaip.2023.09.015","article-title":"Increased Risk of New-Onset Asthma After COVID-19: A Nationwide Population-Based Cohort Study","volume":"12","author":"Kim","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026010701512386000_12.1.e002664.22","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.jaip.2024.03.035","article-title":"Long-Term Impacts of COVID-19 on Severe Exacerbation and Mortality in Adult Asthma: A Nationwide Population-Based Cohort Study","volume":"12","author":"Lee","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026010701512386000_12.1.e002664.23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/rccm.202404-0767RL","article-title":"Risk of Suicide in Individuals with Idiopathic Pulmonary Fibrosis: A Nationwide Cohort Study","volume":"210","author":"Kim","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026010701512386000_12.1.e002664.24","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/jamaneurol.2023.0932","article-title":"Rheumatoid Arthritis and Risk of Parkinson Disease in Korea","volume":"80","author":"Kang","year":"2023","journal-title":"JAMA Neurol"},{"key":"2026010701512386000_12.1.e002664.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.10.006"},{"key":"2026010701512386000_12.1.e002664.26","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-013-2833-x"},{"key":"2026010701512386000_12.1.e002664.27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41375-024-02477-3","article-title":"Rheumatoid arthritis and the risk of hematologic malignancies: a nationwide cohort study","volume":"39","author":"Cho","year":"2025","journal-title":"Leukemia"},{"key":"2026010701512386000_12.1.e002664.28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40658-9","article-title":"Smoking behavior change and the risk of pneumonia hospitalization among smokers with diabetes mellitus","volume":"13","author":"Han","year":"2023","journal-title":"Sci Rep"},{"key":"2026010701512386000_12.1.e002664.29","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/cid\/ciad373","article-title":"Increased Lung Cancer Risk and Associated Risk Factors in Tuberculosis Survivors: A Korean Population-Based Study","volume":"77","author":"Moon","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026010701512386000_12.1.e002664.30","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/cid\/ciac946","article-title":"Tuberculosis and the Risk of Ischemic Heart Disease: A Nationwide Cohort Study","volume":"76","author":"Lee","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026010701512386000_12.1.e002664.31","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/all.15638","article-title":"Overall and respiratory mortality reduction with physical activity in subjects with and without asthma","volume":"78","author":"Lee","year":"2023","journal-title":"Allergy"},{"key":"2026010701512386000_12.1.e002664.32","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-023-03189-2","article-title":"Systemic sclerosis and risk of bronchiectasis: a nationwide longitudinal cohort study","volume":"25","author":"Yang","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"2026010701512386000_12.1.e002664.33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pulmoe.2022.10.002","article-title":"Tuberculosis and risk of Parkinson\u2019s disease: A nationwide cohort study","volume":"29","author":"Yoo","year":"2023","journal-title":"Pulmonology"},{"key":"2026010701512386000_12.1.e002664.34","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/j.jaip.2023.04.044","article-title":"Impact of Allergic Disease on the Risk of Mycobacterial Disease","volume":"11","author":"Kim","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026010701512386000_12.1.e002664.35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2024-002694","article-title":"COVID-19 and risk of long-term mortality in COPD: a nationwide population-based cohort study","volume":"12","author":"Lee","year":"2025","journal-title":"BMJ Open Resp Res"},{"key":"2026010701512386000_12.1.e002664.36","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-025-03123-x","article-title":"Risk of acute exacerbation of chronic obstructive pulmonary disease after COVID-19 recovery: a nationwide population-based cohort study","volume":"26","author":"Kim","year":"2025","journal-title":"Respir Res"},{"key":"2026010701512386000_12.1.e002664.37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jaip.2024.11.013","article-title":"Asthma Increases Long-Term Risk of Death by Suicide: A Nationwide Population-Based Cohort Study","volume":"13","author":"Kim","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026010701512386000_12.1.e002664.38","doi-asserted-by":"crossref","unstructured":"Kim T , Choi H , Kim SH , et al . Increased Risk of Incident Chronic Obstructive Pulmonary Disease and Related Hospitalizations in Tuberculosis Survivors: A Population-Based Matched Cohort Study. J Korean Med Sci 2024;39. doi:10.3346\/jkms.2024.39.e105","DOI":"10.3346\/jkms.2024.39.e105"},{"key":"2026010701512386000_12.1.e002664.39","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-024-02963-3","article-title":"Risk of incident chronic obstructive pulmonary disease during longitudinal follow-up in patients with nontuberculous mycobacterial pulmonary disease","volume":"25","author":"Kim","year":"2024","journal-title":"Respir Res"},{"key":"2026010701512386000_12.1.e002664.40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2023-001789","article-title":"Impacts of regular physical activity on hospitalisation in chronic obstructive pulmonary disease: a nationwide population-based study","volume":"11","author":"Yang","year":"2024","journal-title":"BMJ Open Respir Res"},{"key":"2026010701512386000_12.1.e002664.41","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1295457","article-title":"Risk of newly diagnosed interstitial lung disease after COVID-19 and impact of vaccination: a nationwide population-based cohort study","volume":"11","author":"Kim","year":"2023","journal-title":"Front Public Health"},{"key":"2026010701512386000_12.1.e002664.42","doi-asserted-by":"publisher","DOI":"10.1002\/art.10524"},{"key":"2026010701512386000_12.1.e002664.43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/acr.23426","article-title":"Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis","volume":"70","author":"Accortt","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026010701512386000_12.1.e002664.44","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.128637"},{"key":"2026010701512386000_12.1.e002664.45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/art.39399","article-title":"Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026010701512386000_12.1.e002664.46","article-title":"Incidence and Risk Factors for Infections Requiring Hospitalization, Including Pneumocystis Pneumonia, in Japanese Patients with Rheumatoid Arthritis","volume":"2017","author":"Hashimoto","year":"2017","journal-title":"Int J Rheumatol"},{"key":"2026010701512386000_12.1.e002664.47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acr.25045","article-title":"2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases","volume":"75","author":"Bass","year":"2023","journal-title":"Arthritis Care & Research"},{"key":"2026010701512386000_12.1.e002664.48","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10030509","article-title":"The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review","volume":"10","author":"Taylor","year":"2021","journal-title":"J Clin Med"},{"key":"2026010701512386000_12.1.e002664.49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179179","article-title":"Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan","volume":"12","author":"Mori","year":"2017","journal-title":"PLoS ONE"},{"key":"2026010701512386000_12.1.e002664.50","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-015-0880-2","article-title":"Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials","volume":"17","author":"Strand","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2026010701512386000_12.1.e002664.51","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez087"},{"key":"2026010701512386000_12.1.e002664.52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1515\/jom-2022-0177","article-title":"Glucocorticoid use in rheumatoid arthritis patients and the onset of pneumonia: a systematic review and meta-analysis","volume":"123","author":"Elsouri","year":"2023","journal-title":"J Osteopath Med"},{"key":"2026010701512386000_12.1.e002664.53","doi-asserted-by":"publisher","DOI":"10.1002\/art.22600"},{"key":"2026010701512386000_12.1.e002664.54","first-page":"37","article-title":"Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study","volume":"37","author":"Paalanen","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2026010701512386000_12.1.e002664.55","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/imj.14463","article-title":"Repeat serological testing for anti-citrullinated peptide antibody after commencement of therapy is not helpful in patients with seronegative rheumatoid arthritis","volume":"50","author":"Reid","year":"2020","journal-title":"Intern Med J"},{"key":"2026010701512386000_12.1.e002664.56","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/1756-185X.13000","article-title":"Only rheumatoid factor-positive subset of anti-citrullinated peptide\/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide\/protein antibody-positive","volume":"20","author":"Hiwa","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"2026010701512386000_12.1.e002664.57","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq190"},{"key":"2026010701512386000_12.1.e002664.58","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-019-1909-8","article-title":"Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort","volume":"21","author":"Mouterde","year":"2019","journal-title":"Arthritis Res Ther"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2024-002664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:52:45Z","timestamp":1767779565000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2024-002664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,9,25]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjresp-2024-002664"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2024-002664","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}